VVZ API is not affiliated with ETH Zurich. Data might be outdated or incorrect. Please view the official ETHZ Vorlesungsverzeichnis for binding information.
Pharma Product Strategy
Last Updated: 2026-06-01 11:33:49
Abstract
The course covers the key concepts and strategic frameworks used in the late-stage development and commercialization of medicines, including Go-To-Market (commercial, medical and patient affairs) strategy, asset and portfolio management and other related topics.
Objective
- Participants have a high-level understanding of the key strategic questions and decision points along the lifecycle of a drug: from research to commercialization, enabling them to understand how biopharmaceutical companies connect the dots between the different disciplines/ functions to bring medicines to patients. - Students understand the Go-To-Market strategy in the pharmaceutical companies. They have detailed insights into the functions involved (incl. Medical Affairs, Patient Affairs, Sales and Marketing) and understand where collaboration/ interdependencies among those functions is required. - Participants have a deeper understanding of the asset and portfolio strategy in the biopharmaceutical industry. They are able to explain how a company can strengthen their internal portfolio with external business development opportunities (incl. partnerships, licensing, mergers & acquisitions). - Students are able to discuss case studies and tackle real-life examples of how companies executed on some of those strategies. They will place a special focus on the interconnection of functions, and decision making along the pharmaceutical product value chain.
Content
- Pharmaceutical product lifecycle, value inflection points along the product development and commercialization, success KPIs in the development of medicines - The role of medical affairs, patient affairs, sales and marketing functions; the mandates these functions have and the methodologies they use to bring medicines to patients - Methodologies for asset valuation and portfolio management in the biopharmaceutical company, qualitative and quantitative considerations on business development / mergers & acquisitions - Use cases / examples of the pharmaceutical industry showcasing some of the learnings
General Information
- Language
- English
- Levels
- MSC
- Frequency
- Yearly recurring
Examination
- Type
- graded semester performance
Registration & Places
- Max Places
- 20
Course Components
| Type | Title | Time & Place | Hours |
|---|---|---|---|
| lecture with exercise |
Pharma Product Strategy
Permission from lecturers required for all students.
Block course (see special program:
)
Room HCP E47.2
|
No time listed | 16 h semesterly |